Selpercatinib, a first-in-class, potent RET kinase inhibitor with central nervous system activity, shows sustained, significant improvements in progression-free survival (PFS) and overall survival (OS ...

CHAPEL HILL, N.C. (WTVD) -- UNC Lineberger is leading a new trial into a possible treatment option for anaplastic thyroid cancer. "This is the one cancer diagnosis that I personally dread having to ...

SAN ANTONIO – Genetic testing offered the Garcia family a chance at catching cancer in an earlier stage and treating it before the cancer took on an aggressive form for Martin Garcia, Sr. and nearly ...